Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -20.02-3.593.8626.35-4.60

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -20.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-20.02
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 -20.02
Negative
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹377.1 Cr 3% 17.6% -22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

3%

17.6%

-22.9%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses